WORLAND STEPHEN T 4
4 · eFFECTOR Therapeutics, Inc. · Filed May 17, 2022
Insider Transaction Report
Form 4
WORLAND STEPHEN T
DirectorPresident and Chief Executive
Transactions
- Award
Common Stock
2022-05-13$1.53/sh+1,837$2,811→ 194,978 total
Holdings
- 562,339(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]These shares were acquired under the eFFECTOR Therapeutics, Inc. 2021 Employee Stock Purchase Plan.
- [F2]The Form 4 previously filed on behalf of the Reporting Person on August 27, 2021 inadvertently overstated the number of shares held directly following the transactions reported therein. This reflects the correct number of shares directly and indirectly held by the Reporting person following the previously reported transactions and the transaction reported herein.